Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310983 · ClinicalTrials.gov registry record
Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 254
- Enrollment target
NCT03310983 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 254 participants.
The verdict
NCT03310983 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 254 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2022-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03310983
The ClinicalTrials.gov registry entry for NCT03310983 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03310983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03310983 about?
NCT03310983 is a clinical study titled "Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation". The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
What is the current status of trial NCT03310983?
This trial is currently completed. The enrollment target is 254 participants. The study started on 2017-11-01. Estimated completion is 2022-08-31.
Who is sponsoring clinical trial NCT03310983?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.